Rafael Holdings, Inc. Class B Common Stock

Go to Rafael Holdings, Inc. Class B Common Stock Website

$1.69

0.00 (0.00%)
Live
Previous Close

$1.69

Day Range

$0 - $0

Previous Day Range

$1.67 - $1.76

Market Cap

$61.1 million USD

Day Vol.

0

Previous Day Vol.

72564

Currency

USD

Primary Exchange

New York Stock Exchange

Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet m...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Rafael Holdings announced that CEO Bill Conkling will be stepping down, with Executive Chairman Howard Jonas assuming the CEO role. The company is focused on the development of its lead clinical candidate, Trappsol® Cyclo™, for the treatment of Niemann-Pick Disease Type C1.

Related tickers: RFL, RFL.WS.

Read Full Article

Rafael Holdings has completed its merger with Cyclo Therapeutics, a biotechnology company focused on developing treatments for Niemann-Pick Disease Type C1. The combined company will focus on advancing Cyclo's lead clinical candidate, Trappsol® Cyclo™, which is currently in a Phase 3 trial for NPC1.

Related tickers: CYTH, CYTHW, RFL.

Read Full Article
Trending Tickers

Please sign in to view